Level 1

Congratulations! You leveled up, but you aren't logged in so we can't save your points.

0 Hypes | 0 Bashes

Dr. Grupp Discusses CTL019

Findings from continued clinical studies of investigational chimeric antigen receptor (CAR) therapy, CTL019, demonstrate its potential role in the treatment of certain types of lymphocytic leukemia. In one long-term study of pediatric patients with acute lymphoblastic leukemia (ALL), results showed that 36 of 39 pediatric patients with relapsed/refractory (r/r) ALL, or 92%, experienced complete remissions (CR) with CTL0191. To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7393851-novartis-new-ctl019-clinic-data-acute-lymphoblastic-leukemia/

Show More
  • Ah HA! Uncle Vernon was right!
  • Words with Nazis
  • Selfie of the year
  • Kid Stares Down Elephant Seal
  • Amazing pass, and it doesn't even involve a puck
  • These things happen
  • Pizza with extra sausage
  • Just hanging out